YAC tripeptide of epidermal growth factor promotes the proliferation of HaCaT keratinocytes through activation of EGFR |
Yoo, Yeon Ho
(Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University)
Kim, Yu Ri (Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University) Kim, Min Seo (Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University) Lee, Kyoung-Jin (Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University) Park, Kyeong Han (Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University) Hahn, Jang-Hee (Department of Anatomy and Cell Biology, School of Medicine, Kangwon National University) |
1 | Doma, E., Rupp, C. and Baccarini, M. (2013) EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers. Int. J. Mol. Sci. 14, 19361-19384. DOI |
2 | Nanba, D., Toki, F., Barrandon, Y. and Higashiyama, S. (2013) Recent advances in the epidermal growth factor receptor/ ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J. Dermatol. Sci. 72, 81-86. DOI ScienceOn |
3 | Yarden, Y. and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137. DOI ScienceOn |
4 | Hynes, N. E. and Lane, H. A. (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354. DOI ScienceOn |
5 | Ching, Y. H., Sutton, T. L., Pierpont, Y. N., Robson, M. C. and Payne, W. G. (2011) The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty 11, e41. |
6 | Gembitsky, D. S., Bozso, Z., O'Flaharty, M., Otvos, F., Murphy, R. F. and Lovas, S. (2002) A specific binding site for a fragment of the B-loop of epidermal growth factor and related peptides. Peptides 23, 97-102. DOI ScienceOn |
7 | Dreux, A. C., Lamb, D. J., Modjtahedi, H. and Ferns, G. A. A. (2006) The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis. Atherosclerosis 186, 38-53. DOI ScienceOn |
8 | Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J. H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M. and Yokoyama, S. (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775-787. DOI ScienceOn |
9 | Komoriya, A., Hortsch, M., Meyers, C., Smith, M., Kanety, H. and Schlessinger, J. (1984) Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region. Proc. Natl. Acad. Sci. U.S.A. 81, 1351-1355. DOI |
10 | Pastore, S., Mascia, F., Mariani, V. and Girolomoni, G. (2008) The epidermal growth factor receptor system in skin repair and inflammation. J. Invest. Dermatol. 128, 1365-1374. DOI ScienceOn |
11 | Prausnitz, M. R. and Langer, R. (2008) Transdermal drug delivery. Nat. Biotechnol. 26, 1261-1268. DOI ScienceOn |
12 | Guo, A., Villen, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., Wang, Y., MacNeill, J., Mitchell, J., Gygi, S. P., Rush, J., Polakiewicz, R. D. and Comb, M. J. (2008) Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. U.S.A. 105, 692-697. DOI ScienceOn |
13 | Bancroft, C. C., Chen, Z., Yeh, J., Sunwoo, J. B., Yeh, N. T., Jackson, S., Jackson, C. and Van Waes, C. (2002) Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF- and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer 99, 538-548. DOI ScienceOn |
14 | Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S. and DiGiovanni, J. (2004) Epidermal growth factor receptor- mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 64, 2382-2389. DOI ScienceOn |
15 | Nemoto, W., Saito, A. and Oikawa, H. (2013) Recent advances in functional region prediction by using structural and evolutionary information - Remaining problems and future extensions. Comput. Struct. Biotechnol. J. 8, e201308007. DOI |
16 | Rodrigues, G. A., Falasca, M., Zhang, Z., Ong, S. H. and Schlessinger, J. (2000) A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol. Cell. Biol. 20, 1448-1459. DOI |
17 | Lo, H. W., Hsu, S. C. and Hung, M. C. (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast. Cancer Res. Treat. 95, 211-218. DOI |
18 | Gu, H. and Neel, B. G. (2003) The "Gab" in signal transduction. Trends. Cell Biol. 13, 122-130. DOI ScienceOn |
19 | Yart, A., Laffargue, M., Mayeux, P., Chretien, S., Peres, C., Tonks, N., Roche, S., Payrastre, B., Chap, H. and Raynal, P. (2001) A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen- activated protein kinases by epidermal growth factor. J. Biol. Chem. 276, 8856-8864. DOI ScienceOn |
20 | Liebmann, C. (2001) Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell. Signal. 13, 777-785. DOI ScienceOn |
21 | Vivanco, I. and Sawyers, C. L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501. DOI ScienceOn |
22 | Kirisits, A., Pils, D. and Krainer, M. (2007) Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. Int. J. Biochem. Cell Biol. 39, 2173-2182. DOI ScienceOn |
23 | Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y. and Hung, M.-C. (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell. 7, 575-589. DOI ScienceOn |
24 | Nakamura, T., Takasugi, H., Aizawa, T., Yoshida, M., Mizuguchi, M., Mori, Y., Shinoda, H., Hayakawa, Y. and Kawano, K. (2005) Peptide mimics of epidermal growth factor (EGF) with antagonistic activity. J. Biotechnol. 116, 211-219. DOI ScienceOn |
25 | Bild, A. H., Turkson, J. and Jove, R. (2002) Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J. 21, 3255-3263. DOI ScienceOn |
26 | Debidda, M., Wang, L., Zang, H., Poli, V. and Zheng, Y. (2005) A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 280, 17275-17285. DOI ScienceOn |